Disease-modifying therapies used to treat multiple sclerosis and the gut microbiome: a systematic review

被引：0
|
作者：
Chia-Chen Tsai
Sophia Jette
Helen Tremlett
机构：
[1] University of British Columbia,Division of Neurology, Faculty of Medicine, Djavad Mowafaghian Centre for Brain Health, Room S126, 2211 Wesbrook Mall
[2] University of British Columbia,Faculty of Medicine
来源：
Journal of Neurology | 2024年 / 271卷
关键词：
Multiple sclerosis; Disease-modifying therapy; Gut microbiome; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1108 / 1123
页数：15
相关论文
共 50 条
  • [1] Disease-modifying therapies used to treat multiple sclerosis and the gut microbiome: a systematic review
    Tsai, Chia-Chen
    Jette, Sophia
    Tremlett, Helen
    JOURNAL OF NEUROLOGY, 2023, 271 (3) : 1108 - 1123
  • [2] Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis
    Rae-Grant, Alexander
    Day, Gregory S.
    Marrie, Ruth Ann
    Rabinstein, Alejandro
    Cree, Bruce A. C.
    Gronseth, Gary S.
    Haboubi, Michael
    Halper, June
    Hosey, Jonathan P.
    Jones, David E.
    Lisak, Robert
    Pelletier, Daniel
    Potrebic, Sonja
    Sitcov, Cynthia
    Sommers, Rick
    Stachowiak, Julie
    Getchius, Thomas S. D.
    Merillat, Shannon A.
    Pringsheim, Tamara
    NEUROLOGY, 2018, 90 (17) : 789 - 800
  • [3] Adverse psychiatric effects of disease-modifying therapies in multiple Sclerosis: A systematic review
    Gasim, Majid
    Bernstein, Charles N.
    Graff, Lesley A.
    Patten, Scott B.
    El-Gabalawy, Renee
    Sareen, Jitender
    Bolton, James M.
    Marriott, James J.
    Fisk, John D.
    Marrie, R. A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 26 : 124 - 156
  • [4] Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
    Francesca Washington
    Dawn Langdon
    Journal of Neurology, 2022, 269 : 1861 - 1872
  • [5] Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
    Washington, Francesca
    Langdon, Dawn
    JOURNAL OF NEUROLOGY, 2022, 269 (04) : 1861 - 1872
  • [6] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [7] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [8] Disease-modifying therapies for multiple sclerosis
    John R. Corboy
    Douglas S. Goodin
    Elliot M. Frohman
    Current Treatment Options in Neurology, 2003, 5 (1) : 35 - 54
  • [9] Disease-modifying therapies in multiple sclerosis: A focused review of rituximab
    Alping, Peter
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 133 (05) : 550 - 564
  • [10] Cost-Effectiveness of Multiple Sclerosis Disease-Modifying Therapies: A Systematic Review of the Literature
    Yamamoto, David
    Campbell, Jonathan D.
    AUTOIMMUNE DISEASES, 2012, 2012
12345